Posted In: Health
The biotechnology company Amgen produces two drugs for anemia that have earned the company billions of dollars. But new findings could result in strong warnings being placed on the drugs. Amgen CEO Kevin Sharer talked about his company's situation with Kai Ryssdal.
General David Petraeus told Congress today that he believes the United States can reduce its presence in Iraq to pre-surge levels by next summer. Steve Henn reports that American defense contractors see that as a business opportunity.
Posted In: Retail
U.S. and Chinese regulators are expected to adopt new standards to prevent products containing lead paint from entering the United States. But, as Amy Scott reports, with the holiday shopping season approaching, the toy industry is taking matters into its own hands.